http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0711092-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d0f1ef1aa86daba21657283ec32f529 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D225-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-33 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D225-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 |
| filingDate | 2007-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c2d9427074fad6c400a3986a18942b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06732c3bb42e58e2ad3761119368c4c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40e320026fd54d3fb03e5fce387ff870 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_215e7c01d941015550980501c230e87e |
| publicationDate | 2011-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI0711092-A2 |
| titleOfInvention | compound or a pharmaceutically acceptable salt thereof, pharmaceutical composition, use of a 17-oximacbecin analog, disease treatment methods, and for the production of a 17-oximacbecin analog, host strain, process for producing 17-oximacbecin or a analogous thereof, and use of a host strain |
| abstract | COMPOSITE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME, PHARMACEUTICAL COMPOSITION, USE OF ANALOGUE OF 17-OXIMACBECINE, METHODS OF TREATMENT OF DISEASES, AND FOR THE PRODUCTION OF ANALOGUE OF 17-OXIMACBECINE, A HACOZACININE PROCEDURE, HOSPITAL HOSPITAL, HOSPITAL HOSPITAL ANALOGUE OF THE SAME, AND, USE OF A HOSTING CEPA The present invention relates to 17-oximacbecin analogs that are useful, e.g. eg in the treatment of cancer, B-cell malignancies, malaria, fungal infection, diseases of the central nervous system and neurodegenerative diseases, angiogenesis-dependent diseases, autoimmune diseases and / or as a prophylactic pretreatment for cancer. The present invention also provides methods for the production of these compounds and their use in medicine, in particular in the treatment and / or prophylaxis of B-cell cancer or malignancies. |
| priorityDate | 2006-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 409.